Russian Federation: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2024

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in the Russian Federation

The Russian market for medicaments of alkaloids or derivatives thereof was estimated at $X in 2022, remaining relatively unchanged against the previous year. Over the period under review, consumption showed a perceptible descent. Over the period under review, the market attained the peak level at $X in 2012; however, from 2013 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in the Russian Federation

In value terms, production of medicaments of alkaloids or derivatives thereof totaled $X in 2022 estimated in export price. In general, production, however, enjoyed a buoyant expansion. The pace of growth was the most pronounced in 2017 when the production volume increased by X% against the previous year. Production of peaked at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from the Russian Federation

In 2016, after two years of growth, there was significant decline in overseas shipments of medicaments of alkaloids or derivatives thereof, when their volume decreased by X% to X tons. In general, total exports indicated a buoyant expansion from 2012 to 2016: its volume increased at an average annual rate of X% over the last four-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2016 figures, exports increased by X% against 2013 indices. The pace of growth appeared the most rapid in 2015 when exports increased by X% against the previous year. As a result, the exports attained the peak of X tons, and then contracted in the following year.

In value terms, exports of medicaments of alkaloids or derivatives thereof fell remarkably to $X in 2016. Overall, exports continue to indicate a pronounced reduction. The pace of growth appeared the most rapid in 2014 with an increase of X%. Over the period under review, the exports of hit record highs at $X in 2015, and then contracted rapidly in the following year.

Exports by Country

Uzbekistan (X tons), Ukraine (X tons) and Lithuania (X tons) were the main destinations of exports of medicaments of alkaloids or derivatives thereof from Russia, together comprising X% of total exports.

From 2012 to 2016, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Lithuania (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, Uzbekistan ($X), Ukraine ($X) and Kazakhstan ($X) constituted the largest markets for medicaments of alkaloids or derivatives thereof exported from Russia worldwide, with a combined X% share of total exports. Azerbaijan, Lithuania, Latvia, Moldova, Kyrgyzstan, Armenia, Mongolia, Tajikistan and Turkmenistan lagged somewhat behind, together accounting for a further X%.

Lithuania, with a CAGR of X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average export price for medicaments of alkaloids or derivatives thereof stood at $X per ton in 2016, which is down by X% against the previous year. In general, the export price continues to indicate a deep slump. The pace of growth appeared the most rapid in 2013 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2014 to 2016, the average export prices remained at a lower figure.

There were significant differences in the average prices for the major external markets. In 2016, amid the top suppliers, the country with the highest price was Kazakhstan ($X per ton), while the average price for exports to Kyrgyzstan ($X per ton) was amongst the lowest.

From 2012 to 2016, the most notable rate of growth in terms of prices was recorded for supplies to Tajikistan (X%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into the Russian Federation

After two years of decline, supplies from abroad of medicaments of alkaloids or derivatives thereof increased by X% to X tons in 2016. Over the period under review, imports, however, showed a perceptible setback. The pace of growth was the most pronounced in 2013 with an increase of X% against the previous year. As a result, imports reached the peak of X tons. From 2014 to 2016, the growth of imports of failed to regain momentum.

In value terms, imports of medicaments of alkaloids or derivatives thereof fell to $X in 2016. In general, imports, however, saw a abrupt decrease. The pace of growth was the most pronounced in 2013 with an increase of X%. As a result, imports attained the peak of $X. From 2014 to 2016, the growth of imports of remained at a lower figure.

Imports by Country

India (X tons), Germany (X tons) and Spain (X tons) were the main suppliers of imports of medicaments of alkaloids or derivatives thereof to Russia, with a combined X% share of total imports.

From 2012 to 2016, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Spain (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments of alkaloids or derivatives thereof suppliers to Russia were Germany ($X), India ($X) and Hungary ($X), with a combined X% share of total imports. Italy, Bulgaria, France, Spain, Romania, Pakistan, Greece and the UK lagged somewhat behind, together comprising a further X%.

In terms of the main suppliers, Spain, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced a decline.

Import Prices by Country

In 2016, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, reducing by X% against the previous year. In general, the import price continues to indicate a deep downturn. The most prominent rate of growth was recorded in 2013 when the average import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2014 to 2016, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2016, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2016, the most notable rate of growth in terms of prices was attained by Bulgaria (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :